CGRP Forum is made possible thanks to support from AbbVie, Lilly, Organon and Pfizer, all of whom have no influence or control of editorial content. More information is available here »

Latest:

Positive data reported for eptinezumab in Sunrise trial New insights on treatment holidays with erenumab Dual CGRP ligand mAb and gepant therapy reduces headache severity CGRP-mAb switching yields migraine day reduction Lower switching rates with atogepant than CGRP mAbs EMBRACE shows erenumab reduces migraine severity Older patients benefit from CGRP mAbs too DELIVER shows long term QoL benefits with eptinezumab

Professor Joost Haan MD, PhD

Editorial Board

Department of Neurology

Alrijne Hospital
Simon Smitweg 1
2353GA Leiderdorp
The Netherlands

Leiden University Medical Centre
PO Box 2600
2300RC Leiden
The Netherlands

Joost Haan, MD, PhD, born 21-7-1956, works as a neurologist at Leiden University Medical Center and the Alrijne Hospital Leiderdorp. He received his medical degree in 1982, his speciality certificate in Neurology in 1988 and his PhD on “Hereditary amyloidosis” in 1990. His research is on the genetics of headache and stroke. He (co-)authored many peer-reviewed publications and several books, mainly on clinical genetics. He also published several books on Neurology and Literature (eg. Migraine als Muze and De Trillende Tuinman en andere Parkinsonbeelden). He finished his BA of Film- and Literary Studies at Leiden University in 2015.

« Back to Editorial Board

Educational Partners and Supporters

This program is funded in part via an independent educational grant from AbbVie.

Organon has provided sponsorship towards this independent resource. Organon has had no editorial input or control over content, nor opportunity to influence.

Financial support was provided as GMG Knowledge Gap Grant from Pfizer Inc, Pfizer have provided only financial support and had no input into the content provided.

Editorial PolicyCGRP Forum is an expert resource for clinicians and healthcare professionals working with migraine patients. All patients should discuss their medication with their healthcare professional. Unless otherwise indicated, opinions expressed in the CGRP Education and Research Forum are those of the contributors. Although every effort is made to ensure accuracy and avoid mistakes, no liability on the part of the CGRP Forum, the editors or the editorial board is accepted for the consequences of any misleading or inaccurate information.

Professor Joost Haan MD, PhD

Disclosures

Articles by Joost Haan